Bridgeway Capital Management, LLC Imara Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$3.73 - $5.2 $99,964 - $139,360
-26,800 Reduced 21.19%
99,700 $407,000
Q2 2022

Aug 15, 2022
SELL
$0.99 - $1.87 $15,345 - $28,985
-15,500 Reduced 10.92%
126,500 $154,000
Q1 2022

May 16, 2022
BUY
$1.15 - $2.41 $19,320 - $40,488
16,800 Added 13.42%
142,000 $267,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $7.83 $510,816 - $980,316
125,200 New
125,200 $511,000

Others Institutions Holding IMRA

# of Institutions
3
Shares Held
104K
Call Options Held
0
Put Options Held
170K
View Full List

About IMARA Inc.

IMRA Quotes by TradingView
  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email